Apollon Wealth Management’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
Other funds holding AUTL
Apollon Wealth Management's AUTL Position: Q3 2026 in Review
Apollon Wealth Management reduced its Autolus Therapeutics (AUTL) stake by 0.11% in Q3 2026, selling an estimated $31 and leaving 14,003 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1613.
Apollon Wealth Management first reported a position in AUTL in Q1 2026 and has held it in 3 quarters since. 90 funds tracked by Wall St. Rank hold AUTL as of Q3 2026.
- Apollon Wealth Management held 14,003 shares of Autolus Therapeutics worth $27.2K as of Q3 2026.
- Apollon Wealth Management sold 16 Autolus Therapeutics shares in Q3 2026, an estimated $31.
- Autolus Therapeutics made up ﹤0.01% of Apollon Wealth Management's portfolio in Q3 2026, its #1613 holding.
- Apollon Wealth Management first reported a position in Autolus Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 90 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2026.
Based on Apollon Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.